The oral cavity is a primary target for opportunistic infections in HIV+ patients. Histatins are a family of small molecular weight peptides secreted by human salivary glands that participate in nonimmune defense of the oral cavity. Histatin 5 (Hst-5) is the primary protective salivary component with potent antifungal properties and reduced in the saliva of AIDS patients. The receptor of Hst-5 on C. albicans cell wall was identified as heat shock protein 70. Heat shock protein 70 binds and transports the Hst-5 molecule delivering it to its cellular target. Therefore, changes in the yeast cell surface could affect the regulation of cell wall proteins and surface receptor expression. C. dubliniensis is a species that has been isolated primarily from HIV+ and AIDS patients and has the ability to rapidly develop drug resistance. In comparison to C. albicans, C. dubliniensis was shown to posses a cell wall with different morphology and composition. These properties could have aided its emergence as an opportunistic pathogen, capable of avoiding host's defense mechanisms, forming biofilms and colonizing the oral cavity. This proposal will test the hypothesis that (A) the modifications in the cell wall of C. dubliniensis consist in part of the down regulation of the receptor to Hst-5, Hsp70 which in turn reduces the susceptibility of C. dubliniensis to Hst-5 (B) oral yeast colonization by C. dubliniensis preferentially in HIV+ patients is related to decreased host salivary histatin levels and minimal fungal expression of Hsp70.
Two aims are planned: 1. Determine the expression of Hsp70 in C. albicans and C. dubliniensis (a) whole cell lysates and (b) cytosolic and cell wall fractions of the yeast cell for both species and (c) Determine susceptibility to Hst-5 of C. dubliniensis and C. albicans grown at room temperature and 37 degrees C in comparison to those of C. albicans cells with extracted cell walls. 2. (a) Determine and compare the levels of salivary Hst-5 in 20 HIV+ patients with oral candidiasis (10 with C. dubliniensis and 10 with C. albicans) and in a matched healthy control group (b) Determine and compare the susceptibility to Hst-5 of the C. dubliniensis and C. albicans isolates recovered from the HIV+ individuals. Completing these aims will provide novel data extending our knowledge related to fungal infections in HIV patients. These data will help to advance our understanding of how fungal virulence factors enhance biofilm formation on oral tissues when these facors occur simultaneously with altered non specific host mucosal defenses, allowing species with proven adaptability such as C. dubliniensis to be preferentially selected.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Small Research Grants (R03)
Project #
5R03DE016257-02
Application #
6915766
Study Section
NIDCR Special Grants Review Committee (DSR)
Program Officer
Nokta, Mostafa A
Project Start
2004-07-01
Project End
2007-04-30
Budget Start
2005-05-01
Budget End
2007-04-30
Support Year
2
Fiscal Year
2005
Total Cost
$74,250
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Dentistry
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Jarrett, Angela M; Cogan, N G; Shirtliff, M E (2015) Modelling the interaction between the host immune response, bacterial dynamics and inflammatory damage in comparison with immunomodulation and vaccination experiments. Math Med Biol 32:285-306
Harro, Janette M; Daugherty, Sean; Bruno, Vincent M et al. (2013) Draft Genome Sequence of the Methicillin-Resistant Staphylococcus aureus Isolate MRSA-M2. Genome Announc 1:
Khan, Shariq A; Fidel Jr, Paul L; Thunayyan, Awdah Al et al. (2013) Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals. J AIDS Clin Res 4:
Metwalli, Khalid H; Khan, Shariq A; Krom, Bastiaan P et al. (2013) Streptococcus mutans, Candida albicans, and the human mouth: a sticky situation. PLoS Pathog 9:e1003616
Peters, Brian M; Shirtliff, Mark E; Jabra-Rizk, Mary Ann (2010) Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 6:e1001067
Peters, Brian M; Zhu, Jingsong; Fidel Jr, Paul L et al. (2010) Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection. FEMS Yeast Res 10:597-604
Shirtliff, Mark E; Krom, Bastiaan P; Meijering, Roelien A M et al. (2009) Farnesol-induced apoptosis in Candida albicans. Antimicrob Agents Chemother 53:2392-401
Meiller, Timothy F; Hube, Bernhard; Schild, Lydia et al. (2009) A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS One 4:e5039
Torres, Sandra R; Garzino-Demo, Alfredo; Meiller, Timothy F et al. (2009) Salivary histatin-5 and oral fungal colonisation in HIV+ individuals. Mycoses 52:11-5
Scheper, Mark A; Shirtliff, Mark E; Meiller, Timothy F et al. (2008) Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells. Neoplasia 10:954-63

Showing the most recent 10 out of 13 publications